Establishing a Cold Chain Management Framework for Global Pharmaceutical Logistics
Supporting stable global supply through temperature control, shipment visibility, and integrated management.
Industry : Pharma
Challenge (Before)
When expanding pharmaceutical products globally, it was essential to design logistics operations that accounted for product-specific temperature requirements as well as compliance with varying GDP regulations across countries and regions.
At the same time, global pharmaceutical logistics often involve multiple logistics providers, resulting in differences in temperature control methods and shipment status monitoring across transport segments. This made it difficult to gain a comprehensive, end-to-end view of the cold chain.
Establishing a framework that would allow timely confirmation of in-transit temperature and location data, and enable appropriate responses based on real-time conditions, emerged as a key challenge.
Solutions
NX Solution
- A dedicated team with deep expertise in pharmaceutical logistics designed an optimized logistics scheme based on product characteristics and country-specific GDP regulations.
- Global pharmaceutical logistics spanning multiple logistics providers and transport modes were centrally managed, ensuring consistent cold chain integrity from warehousing and cargo handling through to final delivery.
- A visualization tool enabling real-time monitoring of temperature and location data at each stage of the logistics process was introduced, allowing shipment status to be tracked in a timely manner.
Benefits
Benefits (Results)
A global pharmaceutical logistics framework compliant with regulatory requirements in each country and region was established, and centralized shipment management ensured end-to-end cold chain consistency.
Through continuous monitoring enabled by the visualization tool, in-transit conditions could be accurately tracked, abnormalities detected at an early stage, and swift corrective actions taken. By consolidating shipment visibility and control, transparency and reliability in quality management were enhanced, supporting a stable and dependable global supply of pharmaceutical products.
